JNJ Restructuring Expected to Impact DePuy Synthes

Johnson & Johnson (JNJ), parent company of DePuy Synthes, will undertake restructuring actions in its Medical Devices business, including changes to the orthopaedics segment. JNJ cited business exits and staff reductions as it seeks pre-tax cost savings of up to $1 billion by end of 2018.

AAOS 2016: First-time Exhibitors to Meet

As you prepare to attend the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, we present to you a list of first-time exhibitors with product development initiatives that you may find of interest.

U.S. Federal Court Dismisses Arthrex’s Claims Against KFx Medical

A U.S. Federal Court has dismissed all of Arthrex’s claims against KFx Medical from a suit filed in 3Q15.